Sources Believe Rite Aid/Walgreens Deal Likely Completes

Notwithstanding the apparent market consensus, it is more likely than not the Rite Aid/Walgreens merger is ultimately approved by the Federal Trade Commission, various antitrustfeatured

Ken Wolter /

Luxottica/Essilor Pre-Filing Discussions Focused on Conglomerate Issues

With additional reporting by Valeria Camerino – Questions over whether a merged Luxottica/Essilor could potentially foreclose competitors is extending the pre-notification discussion periodfeatured

Small Divestiture Possible in C.R. Bard/Becton Dickinson Deal

Becton, Dickinson received a second request for additional information from the Federal Trade Commission on June 9 regarding its pending acquisition of C.R. Bard. The second request is notfeatured

Delrahim Vote Expected to be Positive for Time Warner/AT&T

The October 2016 announced Time Warner/AT&T merger is plodding through the Department of Justice’s investigation and remains on track to close by year’s end, antitrust sourcesfeatured

Phase II Review About to Begin in NXP/Qualcomm Merger

The NXP Semiconductors acquisition by Qualcomm will be tipped into a phase II review by the European Commission on June 9, two antitrust sources close to the case told CTFN.featured

Bayer Acquisition of Monsanto Likely to Extend into 2018, Sources Say

Industry sources believe that the Bayer acquisition of Monsanto will be delayed into 2018.  Bayer has not yet filed with Brussels authorities for its takeover of Monsanto and is takingfeatured

360b /

Rite Aid and Walgreens Waiting on FTC Commissioners

An attorney who previously worked with a third party in the merger of Rite Aid and Walgreens Boots Alliance told CTFN that the Federal Trade Commission has ramped up its resourcesfeatured

Ken Wolter /

Two Parties Complaining to EC about NXP/Qualcomm Deal

Qualcomm only has two complainants at the European Commission about its deal with NXP, a source close to the situation told CTFN. “The state of play was earlier this week but despite bothfeatured

Qualcomm Not Expected to Offer EC Phase I Remedies

With additional reporting by Diane Alter – Qualcomm does not intend to offer remedies to the European Commission during Phase I of the EC’s review of Qualcomm’s acquisition of NXP Semiconductors, a source close tofeatured

Valspar/Sherwin Williams Remedy Package Judged Sufficient by Sources

The Valspar/Sherwin-Williams merger will be approved by the Federal Trade Commission, with a remedy package along the lines of the divestiture to Axalta that Sherwin previouslyfeatured


Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.